Taishi Onodera

Title: Taishi Onodera: Innovator in Norovirus Vaccine Development

Introduction

Taishi Onodera is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of vaccine development, particularly focusing on norovirus. His innovative work has led to the creation of a unique vaccine that addresses critical challenges in immunization.

Latest Patents

Taishi Onodera holds a patent for a composite polypeptide monomer and an aggregate of said composite polypeptide monomer having cell penetration function. This patent also includes a norovirus component vaccine designed for subcutaneous, intradermal, percutaneous, or intramuscular administration. The invention aims to provide a vaccine that can effectively immunize target cells, utilizing a molecular needle as an active ingredient. The associated product includes a hexamer formed through bonding of two molecules of a trimer of a molecular needle, which is represented by a specific formula.

Career Highlights

Throughout his career, Taishi Onodera has worked with notable organizations, including the Kitasato Institute and Denka Company Limited. His experience in these institutions has allowed him to refine his expertise in vaccine research and development.

Collaborations

Taishi Onodera has collaborated with several professionals in his field, including Megumi Mano and Reiko Todaka. These collaborations have contributed to the advancement of his research and the successful development of his patented vaccine.

Conclusion

Taishi Onodera's innovative work in the field of norovirus vaccine development showcases his dedication to improving public health. His contributions through his patent and collaborations highlight the importance of research in combating viral infections.